Retrospective Follow-up Study of Synvisc® in Patients With Knee Osteoarthritis

Synvisc® in Knee Osteoarthritis: Retrospective Follow-up in Treated Patients Since at Least Three Years

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02195557

Enrollment

Registered

2014-07-21

Start date

2002-04-30

Completion date

Unknown

Last updated

2014-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Brief summary

Retrospective collection of data, aimed at a better knowledge of the use of Synvisc® among the patients with knee osteoarthritis (OA) since at least three years.

Interventions

DRUGSynvisc®

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* Patients with knee osteoarthritis using Synvisc® since at least three years

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame	Description
Reason for prescription	at least 3 years before start of observation period	—
Number of other treatments per patient	at least 3 years of observation	antalgics, non-steroid anti-inflammatory drugs (NSAIDs), steroid anti-inflammatory drugs (SAIDs), specific symptomatic treatments and surgery
Time between two treatments	at least 3 years of observation	—

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026